Studies on the antiperinuclear factor
1967; Wiley; Volume: 10; Issue: 2 Linguagem: Inglês
10.1002/art.1780100206
ISSN1529-0131
AutoresAlberto M. Marmont, E Damasio, C Bertorello, Ferdinando Rossi,
Tópico(s)Monoclonal and Polyclonal Antibodies Research
ResumoArthritis & RheumatismVolume 10, Issue 2 p. 117-128 ArticleFree to Read Studies on the antiperinuclear factor Alberto M. Marmont M.D., Alberto M. Marmont M.D. Director Centro di Reumatologia and the II Medical Division of the Ospedali Civili di Sampierdarena, Genova, Italy. Libero Docente in Clinica Medica Generate, Patologia Speciale Medica and Ematologia, University of Genoa, ItalySearch for more papers by this authorEugenio E. Damasio, Eugenio E. Damasio Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this authorCesare Bertorello, Cesare Bertorello Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this authorFerdinando Rossi, Ferdinando Rossi Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this author Alberto M. Marmont M.D., Alberto M. Marmont M.D. Director Centro di Reumatologia and the II Medical Division of the Ospedali Civili di Sampierdarena, Genova, Italy. Libero Docente in Clinica Medica Generate, Patologia Speciale Medica and Ematologia, University of Genoa, ItalySearch for more papers by this authorEugenio E. Damasio, Eugenio E. Damasio Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this authorCesare Bertorello, Cesare Bertorello Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this authorFerdinando Rossi, Ferdinando Rossi Assistant Physician II Medical Division, Ospedali Civili di Sampierdarena, Genoa, ItalySearch for more papers by this author First published: April 1967 https://doi.org/10.1002/art.1780100206Citations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Nienhuis, R. L. F., and Mandema, E.: A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann. Rheum. Dis. 23: 302, 1964. 2 Visconti, A., Cava, L., and Fontana, G.: Ricerca del fattore anti-perinucleare ( APF ) nell' artrite reumatoide ed in altre malattie. Osped. Maggiore 59: 1357, 1964. 3 Cava, L., Fontana, G., and Visconti, A.: Ulteriori esperienze sul test di immunofluorescenza perinucleare nella diagnosi dell' artrite reumatoide; in “ Atti del Simposio Internazionale su Recenti Acquisizioni nella Terapia Antireumatica Non-steroidea.” Minerva Med. 1965; p. 326. 4 Del Giacco, G. S., and Mazzei, D.: Evidenziazione in immunofluorescenza di un fattore serico anti-perinucleare nell' artrite reumatoide. Reumatismo 17: 60, 1965. 5 Nienhuis, R. L. F.: Antiperinucleaire factor. Een nieuwe serologische reactie voor de diagnostiek van reumatoide artritis. Proefschrift, Rijksuniversiteit te Groningen, 1965. 6 Montagna, W.: The structure and function of skin. New York, Academic Press, 1962. 7 Listgarten, M. A.: The ultrastructure of human gingival epithelium. Amer. J. Anat. 114: 49, 1964. 8 Marmont, A., and Damasio, E.: Gli anticorpi antinucleari in reumatologia. II contribute dell' immunofluorescenza. Atti XIII Giornate Reumatologiche Romane 12–13 Marzo, 1966 (in press). 9 Marmont, A., Rossi F., Bordo, D., and Damasio, E.: Rara associazione di sindrome di Sjögren e di malattia di Weber-Christian. Inquadramento delle ipodermiti nodulari »idiopatiche« fra le mesenehimopatie. Ospedale Sampierdarena 5: 9, 1965. 10 Silver, M., Berkowitz, J., and Steinbrocker, O.: Rheumatic manifestations of systemic lupus erythematosus. Bull. Hosp. Joint. Dis. 18: 152, 1957. 11 Bateman, M., Malins, J. M., and Meynell, M. J.: Rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 17: 114, 1950. 12 Gsell, O., and Miescher, P. A.: Die Beziehungen zwischen der primär Polyarthritis und dem visceralen Erythematodes auf Grand serologischer Reaktionen. Helv. Med. Acta 25: 437, 1958. 13 Kunkel, H. G.: Immunologic aspects of rheumatoid arthritis. J. Chronic Dis. 10: 418, 1959. 14 Boni, A.: Klinik der primar chronischen Polyarthritis und ihrer Grenzfalle unter besonderer Berücksichtigung der serologischen Probleme. Schweiz. Med. Wschr. 90: 755, 1960. 15 Martin, E.: Polyarthrite chronique évolutive et lupus érythémateux disséminé. Schweiz. Med. Wschr. 13: 370, 1962. 16 Marcolongo, F., Carcassi, U., and Marcolongo, R.: L' artrite reumatoide. Il Pensiero Scientifico, Roma, 1963. 17 Patrassi, G., and Ghiotto, G.: In tema di Collagenosi di transizione. Atti X Giornate Reumatologiche Romane, Il Pensiero Scientifico, Roma, 1963, p. 55. 18 Marmont, A., and Damasio, E.: I fattori anti-nucleari nella cosiddetta artrite rheumatoide maligna. Reumatismo 15: 163, 1963. 19 Kunkel, H. G., and Williams, R. C.: Rheumatoid arthritis. Ann. Rev. Med. 15: 37, 1964. 20 Delbarre, F., Amor, B., and Rochan, H.: Critères du diagnostic, du pronostic et pour la conduite du traitement dans le rhumatisme lupique. In “ Problèmes actuels de rhumatologie”; Zollikofer & Co., St. Gallen. 1965, p. 70. 21 Mori, R.: Il lupus eritematoso. Piccin. Padova, 1965. 22 E. L. Dubois (Ed.): Lupus erythematosus. New York, McGraw-Hill, 1966. 23 Feltkamp, T. E. W.: Idiopathic autoimmune diseases. A study of their serological relationship. Proefschrift, Universiteitt van Amsterdam, 1966. 24 Beck, J. S., Anderson, J. R., Bloch, K. J., Buchanan, W. W., and Bunim, J. J.: Anti-nuclear and precipitating auto-antibodies in Sjögren's syndrome. Ann. Rheum. Dis. 24: 16, 1965. 25 Meltzer, M., Franklin, E. C., Elias, K., McCluskey, R. T., and Cooper, N.: Cryoglobulinemia—A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Amer. J. Med. 40: 837, 1966. 26 Duthie, J. J. R., Brown, P. E., Truelove, L., Baragar, H., and Lawrie, A. J.: Course and prognosis in rheumatoid arthritis. Ann. Rheum. Dis. 23: 193, 1964. 27 Lansbury, J.: Methods for evaluating rheumatoid arthritis. In J. L. Holländer (Ed.) Arthritis and Allied Conditions. Philadelphia. Lea & Febiger, 1960. 28 Marmont, A., Piuma, M. A., and Capponi, G.: Eine einfache, empfidliche und sichere Methode zur Auslösung des L. E. -Phänomens durch mechanische Schädigung der Leukozyten des Substrates, mit besonderer Berücksichtigung der Befunde bei Lupus erythematodes und Polyarthritis chronica. Schweiz. Med. Wschr. 87: 1253, 1957. 29 Antognetti, L., and Marmont, A.: Rheumatoid arthritis and the L. E. factor. Acta Rheum. (Basle), Documenta Geigy, Special Issue: “ Rhematoid Arthritis,” 86–128, 1962. 30 Friedman, I. A., Sickley, J. F., Poske, R. M., Black, A., Bronsky, D., Hartz, W. H., Jr., Feldhake, C., Reader, P. S., and Katz, E. M.: The L. E. phenomenon in rheumatoid arthritis. Ann. Int. Med. 46: 1113, 1957. 31 Fallet, G. H., Vasey, H., Meyer, E., and Spahr, J.: Les polyarthrites chroniques evolutives à cellules L. E. Rev. Rhum, 26: 553, 1959. 32 Goldfine, L. J., Stevens, M. B., Masi, A. T., and Shulman, L. E.: Clinical significance of the L. E. phenomenon in rheumatoid arthritis. Ann. Rheum. Dis. 24: 153, 1965. 33 Kievits, J. H., Goslings, J., Schult, H. R. E., and Hijmans, W.: Rheumatoid arthritis and the positive L. E. phenomenon. Ann. Rheum. Dis. 15: 211, 1956. 34 Marmont, A., and Damasio, E.: Il quadro immunobiologico del lupus eritematoso sistemico con particolare riguardo al fattore L. E.; in “ Immunologia delle malattie reumatiche.” Il Pensiero Scientiflco, Roma, 1961; p. 147. 35 Ward, D. J., Johnson, G. D., and Holborow, E. J.: Antinuclear factor in rheumatoid arthritis: its incidence and clinical significance. Ann. Rheum. Dis. 23: 306, 1964. 36 Debeyre, N., Kahn, M. F., Rickewart, A., and de Seze, S.: Les polyarthrites rhumatoides avec cellules de Hargraves. Présse Méd. 74: 911, 1966. 37 Condemi, J. J., Barnett, E. V., Atwater, E. C., Jacox, R. F., Mongan, E. S., and Vaughan, J. H.: The significance of antinuclear factors in rheumatoid arthritis. Arthritis Rheum. 8: 1080, 1965. 38 Kabat, E. A.: Structure and heterogeneity of antibodies. Acta Haemat. 36: 198, 1966. 39 Barnett, E. V., Bakemeier, R. F., Leddy, J. P., and Vaughan, J. H.: Heterogeneity of antinuclear factors in lupus erythematosus and rheumatoid arthritis. Proc. Soc. Exp. Biol. Med. 118: 803, 1965. 40 Weissmann, G., and Thomas, L.: Steroids, lysosomes and systemic lupus erythematosus. Bull. N. Y. Acad. Med. 38: 779, 1962. 41 Weissmann, G.: Lysosomes, autoimmune phenomena and diseases of connective tissue. Lancet 2: 1373, 1964. 42 Weiss, L., and Dingle, J. T.: Lyososomal activation in relation to connective disease. Ann. Rheum. Dis. 23: 57, 1964. 43 Bartholomew, L. E.: Isolation and characterization of mycoplasma (PPLO) from patients with rheumatoid arthritis, systemic lupus erythematosus and Reiter's syndrome. Arthritis Rheum. 8: 376, 1965. 44 Barnett, E. V., Balduzzi, P., Vaughan, J. H., and Morgan, H. R.: Search for infectious agents in rheumatoid arthritis. Arthritis Rheum. 9: 720, 1966. 45 De Duve, C., and Wattiaux, R.: Functions of lysosomes: Ann. Rev. Physiol. 28: 435, 1966. 46 Tan, E. M., and Kunkel, H. G.: An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum. 9: 37, 1965. 47 Barnes, G. W., Sullivan, M. A., Beutner, E. H., and Witebsky, E.: In vitro and in vivo interaction of nuclear antibodies with corresponding antigens. Experimentia 21: 485, 1965. 48 Jones, B. R.: Lacrymal and salivary precipitating antibodies in Sjögren's syndrome. Lancet 2: 773, 1958. 49 Anderson, J. R. K., Gray, G., Beck, J. S., Buchanan, W. W., and McElhinney, A. J.: Precipitating autoantibodies in the connective tissue diseases. Ann. Rheum. Dis. 21: 360, 1962. 50 Bertram, U., and Halberg, P.: A specific antibody against the epithelium of the salivary ducts in sera from patients with Sjögren's syndrome. Acta Allergol. 19: 458, 1964. 51 Deicher, H. R. G., Holman, H. R., and Kunkel, H. G.: Anticytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases. Arthritis Rheum. 3: 1, 1963. 52 Wiedermann, G., and Miescher, P. A.: Cytoplasmic antibodies in patients with systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 124: p. II, 807, 1965. 53 Sturgill, B. C., and Carpenter, R. R.: Antibodies to ribosomes in systemic lupus erythematosus. Arthritis Rheum. 8: 213, 1963. 54 Wiedermann, G., Hirschhorn, R., Weissmann, G., and Miescher, P.: Antilysosomal »autoantibodies« in patients with systemic lupus erythematosus and hepatitis, in Immunopathology, IVth International Symposium 1965, Schwabe, Basel-Stuttgart 1966, p. 392. 55 Walker, J. G., Doniach, D., Roitt, I. M., and Sherlock, S.: Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1: 827, 1965. 56 Glynn, L. E., and Holborow, E. J.: Autoimmunity and disease. Oxford, Blackwell Scientific Publications, 1965. 57 Del Giacco, G. S.: Personal communication. 58 Kaplan, M. H.: Autoantibodies to heart and rheumatic fever: the induction of autoimmunity to heart by streptococcal antigen cross-reactive with heart. Ann. N. Y. Acad. Sci. 124: p. II, 904, 1963. 59 Rowley, D., and Jenkin, C. R.: Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature 193: 151, 1962. 60 Whittingham, S., Maekay, I. R., and Irvin, J.: Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1: 1333, 1966. Citing Literature Volume10, Issue2April 1967Pages 117-128 ReferencesRelatedInformation
Referência(s)